Cholesterol levels and statin use in patients with coronary heart disease treated in primary care settings. Prev Chronic Dis 2005;2 :A05. 38. Ko DT, Hebert PR, Coffey CS, Curtis JP, et al. Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of...
For patients with diabetes and ASCVD, if the low-density lipoprotein (LDL) cholesterol level is 70 mg/dL (3.9 mmol/L) or above on maximally tolerated statin dose, consider adding additional LDL-lowering therapy (such as ezetimibe or a proprotein convertase subtilisin/kexin type 9 [PCSK9] inhi...
The percentage reduction approach is needed for patients starting statin treatment for secondary prevention or because of their high cardiovascular risk but whose total cholesterol value is already close to the target. For example, for such patients starting statin treatment with a total cholesterol of...
Would she benefit from starting a statin and if so, why? A) Yes, she is diabetic. B) Yes, she is 44 years old. C) No, her LDL is unknown. D) No, need to assess her hemoglobin A1C before deciding to initiate therapy. Answer: A Diabetes is one of the four statin benefit groups...
Role of Nonstatin Therapies in Lowering LDL-Cholesterol during Atherosclerotic Cardiovascular Disease Risk Management View Share View All Guidelines Infographics Articles Oral P2Y12inhibitor pre-treatment for percutaneous coronary intervention in non–ST-elevation acute coronary syndromes: evolving notions in ES...
Statements and grade of recommendations (GOR) for the management of GCA These are a list of the recommendations made in order to address the main clinical questions. Under each part, there is information on the mean degree of agreement among the expert panel members, the percentage of agreement...
Nearly all individuals in their late 60s and early 70s—including 100 percent of men—now qualify for and should consider starting a statin medication to reduce their risk of cardiovascular disease, under the recently released cholesterol guidelines from the American College of Cardiology (ACC) and ...
[1]with a unique focus on the change in paradigm, exposing more patients to statin therapy, and the 4 categories that are deemed to be most likely to benefit from therapy -- one of which is ≥ 7.5% risk over 10 years, which has become the lightning rod for discussions here. Can we ...
When starting a new antihypertensive drug or adjusting its dosage or dosing time, it is recommended to follow-up at least monthly until the target BP is reached to check the adherence to the drug and whether the BP is controlled [105,106]. Stage II or more severe hypertension may be follo...
51 Recently, there have been articles stating the role of statin therapy in significantly reducing the risk of CI-AKI.54 Use of IABP, periprocedural hypotension,13, 50 LVF, primary PCI for AWMI55 all increases risk of CI-AKI. Use of IABP is a marker of hemodynamic instability, an ...